Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Winter 2025 - Critical Care
Download Issue
Share
Up Front
Publisher's Corner
Demand for Quality Care Fuels Healthcare Delivery Advances
By Patrick M. Schmidt
Features
Myths & Facts: Kawasaki Disease
By
Ronale Tucker Rhodes, MS
Meeting the Demand for Personalized Care
By
Trudie Mitschang
Managing Care from Afar: The Challenges and Solutions of Long-Distance Health Management
By
Lee Warren
Hospital at Home: The Future of Care?
By
Rachel Maier, MS
The Expanding Role of Immune Globulin Treatment in Diseases: Utilization and Growth
By
Diane L.M. Cook
BioTrends Watch
Washington Report
Multi-Million Dollar Grant Awarded for Organ Transplantation Research
Guidance for Second Medicare Drug Price Negotiation Released
CMS Issues Final Rule on 2025 Home Health Prospective Payment Systems
HHS Proposes Rule to Advance Health Equity
Reimbursement FAQs
Understanding Drugs and Money in 2025
Healthcare Management
Improving Care and Service by Capturing Patients’ Voices
Industry News
Lab Value Predictive of COVID-19 Disease Severity in Children
FDA Approves Dupixent for Chronic Obstructive Pulmonary Disease
Changes in Immune Cell Gene Activity May Indicate Probability of Developing MS
HIV Vaccine Elicits Potent Response in Nonhuman Primates
CSL Begins Enrollment for Hizentra Study for POTS
mRNA Cancer Vaccine Begins Trials for Non-Small Cell Lung Cancer
Pfizer’s RSV Vaccine ABRYSVO Approved by FDA
Scientists Develop $25 Nasal Spray That Is 99% Effective Against Colds, Flu and COVID-19
First Nasal Self-Administered Flu Vaccine Approved by FDA
New Type of Blood Test Can Identify Kids at Risk of Diabetes
Study Finds Repeat Dosing of IVIG and PLEX Common in GBS, Resulting in Harm to Nonresponders
BioFocus
Industry Insight
In the R&D Pipeline: New Agents to Prevent and Treat Hereditary Angioedema Attacks
By Keith Berman, MPH, MBA
Patient Profile
Lyme Disease: A Patient's Perspective
By Trudie Mitschang
Physician Profile
Lyme Disease: A Physician’s Perspective
By Trudie Mitschang
Disease Profile
Diagnosing and Treating Lyme Disease
By Jim Trageser
BioSources
BioTech
Home Health: Winter 2025